Gain Therapeutics, Inc. Common Stock (GANX) Stock Price

GANXStock

$1.91+1.52%52W

Market Cap$83.14M

P/E—

PEG Ratio—

Div yield—

Beta0.16

GANX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-1.96%

Price vs S&P 500 (4W)12.55%

VGM Score36.55

Book Value / Share (Quarterly)$0.33

P/TBV (Annual)6.71x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.46

Price vs S&P 500 (YTD)-49.85%

Net Profit Margin (TTM)-6393.75%

EPS (TTM)$-0.60

10-Day Avg Trading Volume0.61M

EPS Excl Extra (TTM)$-0.60

EPS (Annual)$-0.89

ROI (Annual)-262.42%

Net Profit Margin (5Y Avg)-15801.64%

Cash / Share (Quarterly)$0.39

ROA (Last FY)-168.36%

EBITD / Share (TTM)$-0.54

ROE (5Y Avg)-129.19%

Operating Margin (TTM)-6506.25%

Cash Flow / Share (Annual)$-0.44

P/B Ratio6.75x

P/B Ratio (Quarterly)5.85x

Net Income / Employee (Annual)$-1,020,600

EV / Revenue (TTM)489.52x

Net Interest Coverage (TTM)-230.50x

ROA (TTM)-136.23%

EPS Incl Extra (Annual)$-0.89

Current Ratio (Annual)6.63x

Quick Ratio (Quarterly)4.51x

3-Month Avg Trading Volume0.76M

52-Week Price Return1.52%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.33

P/S Ratio (Annual)1712.37x

Asset Turnover (Annual)0.00x

52-Week High$4.34

Operating Margin (5Y Avg)-15704.40%

EPS Excl Extra (Annual)$-0.89

CapEx CAGR (5Y)17.60%

26-Week Price Return9.29%

Quick Ratio (Annual)6.46x

13-Week Price Return14.29%

Total Debt / Equity (Annual)0.02x

Current Ratio (Quarterly)4.69x

Enterprise Value$78.32M

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-40210.67%

Cash / Share (Annual)$0.50

3-Month Return Std Dev75.69%

Net Income / Employee (TTM)$-1,062,000

ROE (Last FY)-278.10%

Net Interest Coverage (Annual)-22.87x

EPS Basic Excl Extra (Annual)$-0.89

Receivables Turnover (TTM)0.41x

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$-0.60

Receivables Turnover (Annual)0.72x

ROI (TTM)-193.85%

P/S Ratio (TTM)590.55x

Pretax Margin (5Y Avg)-15753.38%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.44

Price vs S&P 500 (52W)-16.79%

Year-to-Date Return-37.89%

5-Day Price Return-1.48%

EPS Normalized (Annual)$-0.89

ROA (5Y Avg)-86.78%

Net Profit Margin (Annual)-40354.33%

Month-to-Date Return19.05%

Cash Flow / Share (TTM)$-1.43

EBITD / Share (Annual)$-0.89

Operating Margin (Annual)-40328.25%

LT Debt / Equity (Annual)0.02x

ROI (5Y Avg)-122.56%

LT Debt / Equity (Quarterly)0.02x

EPS Basic Excl Extra (TTM)$-0.60

P/TBV (Quarterly)5.89x

P/B Ratio (Annual)6.67x

Pretax Margin (TTM)-6375.00%

Book Value / Share (Annual)$0.44

Price vs S&P 500 (13W)11.49%

Beta0.16x

Revenue / Share (TTM)$0.00

ROE (TTM)-201.43%

52-Week Low$1.53

vGradeF

mGradeC

vgmGradeD

GANX Earnings Surprise History

Q2 25-0.19est. -0.17

Q3 25-0.15est. -0.15

Q4 25-0.11est. -0.14

Q1 26-0.13est. -0.14

Q2 26-0.11est. -0.15

GANX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.27

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
GANXGain Therapeutics, Inc. Common Stock	F	—	C	$1.91
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Gain Therapeutics, Inc. Common Stock

Gain Therapeutics is a clinical-stage biotech company developing novel small molecule therapeutics using its proprietary Magellan platform, which identifies allosteric binding sites on disease-implicated proteins. The company's lead program, GT-02287, targets GBA1 Parkinson's disease, with a broader pipeline addressing lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. Gain operates globally across Switzerland, Spain, the United States, and Australia.